Challenges and promises in modeling dermatologic disorders with bioengineered skin.

Area of Science:

• Biotechnology
• Drug Development
• Tissue Engineering

Background:

• Drug development is expensive due to high failure rates in clinical trials after promising preclinical results.
• Current preclinical models (cell culture, animal studies) often fail to predict human responses accurately.
• Novel technologies are needed to improve the prediction of drug safety and efficacy.

Purpose of the Study:

• To review the potential of three-dimensional engineered skin on microphysiological systems for drug development.
• To discuss the challenges and future directions for bioengineered skin models.
• To highlight the utility of engineered skin in modeling dermatologic disorders.

Main Methods:

• Review of current literature on microtechnology and bioengineered skin.
• Discussion of biological and engineering challenges in creating robust engineered skin.
• Exploration of the application of engineered skin in disease modeling.

Main Results:

• Microphysiological systems allow integration of multiple organ systems on a chip.
• Engineered skin has a history of clinical use and laboratory modeling.
• Engineered skin holds promise for modeling skin diseases and reactions.

Conclusions:

• 3D engineered skin on microchips offers a promising approach to enhance drug safety and efficacy prediction.
• Addressing current biological and engineering challenges is crucial for robust bioengineered skin models.
• This technology can accelerate drug development and improve the modeling of dermatologic conditions.